Identifying pre-sepsis opportunities for early, targeted intervention

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2018
    2023
  • Known Financial Commitments (USD)

    $401,918
  • Funder

    National Institutes of Health (NIH)
  • Principle Investigator

    Pending
  • Research Location

    United States of America, Americas
  • Lead Research Institution

    KAISER FOUNDATION RESEARCH INSTITUTE
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease transmission dynamics

  • Special Interest Tags

    Gender

  • Study Subject

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

ABSTRACT/PROJECT SUMMARYSARS-CoV-2, the novel coronavirus resulting in COVID19 disease, has caused a global pandemic ofunprecedented impact. In just over three months, SARS-CoV-2 spread has infected more than 2 millionindividuals and resulted in at least 150,000 deaths. Non-pharmacologic interventions (NPIs), like socialdistancing and shelter-in-place measures, have proven to be the only effective strategy available today tomitigate rapidly growing outbreaks. However, the effectiveness of social distancing depends on earlyidentification of viral spread, since even short delays in NPIs can result in overwhelming surges in acute illnessand healthcare demand. Unfortunately, current prediction models of SARS-CoV-2 viral spread are based onlagging or incomplete indicators of infections like COVID19 case positivity, hospitalization, or death rates. As aresult, these prediction models may have limited efficacy during the earliest stages of viral spread, when NPIscan have the greatest impact. This project will use methods my laboratory has developed to predict sepsis - alife-threatening infectious disease marked by a dysregulated host response - that incorporate novel real-timedata to identify and compare the value of early indicators of SARS-CoV-2 viral spread. We will compare thepredictive utility of these data in SARS-CoV-2 with influenza, a seasonal viral disease that can cause sepsiswhile also resulting in surges in healthcare demand. We will use a unique source of highly-detailed electronichealth record data arising from an integrated health system with more than 200 medical offices and 21hospitals caring for 4.4 million patients. Our findings will have broad and immediate impact for predictingSARS-CoV-2 viral spread that can inform effective strategies for COVID19 mitigation by patients, clinicians,public health agencies, researchers, and health systems.